ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) Fundamental Analysis & Valuation

OSL:AZT • NO0010014632

Current stock price

19.75 NOK
+0.45 (+2.33%)
Last:

This AZT.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. AZT.OL Profitability Analysis

1.1 Basic Checks

  • In the past year AZT was profitable.
  • AZT had a positive operating cash flow in the past year.
  • AZT had positive earnings in each of the past 5 years.
  • Each year in the past 5 years AZT had a positive operating cash flow.
AZT.OL Yearly Net Income VS EBIT VS OCF VS FCFAZT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M

1.2 Ratios

  • AZT has a better Return On Assets (2.86%) than 74.07% of its industry peers.
  • AZT's Return On Equity of 3.05% is fine compared to the rest of the industry. AZT outperforms 75.31% of its industry peers.
  • The Return On Invested Capital of AZT (0.66%) is better than 74.07% of its industry peers.
Industry RankSector Rank
ROA 2.86%
ROE 3.05%
ROIC 0.66%
ROA(3y)3.64%
ROA(5y)7.51%
ROE(3y)3.94%
ROE(5y)8.46%
ROIC(3y)N/A
ROIC(5y)N/A
AZT.OL Yearly ROA, ROE, ROICAZT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

1.3 Margins

  • AZT's Profit Margin of 9.18% is fine compared to the rest of the industry. AZT outperforms 77.78% of its industry peers.
  • AZT's Profit Margin has declined in the last couple of years.
  • The Operating Margin of AZT (2.50%) is better than 72.84% of its industry peers.
  • AZT's Operating Margin has declined in the last couple of years.
  • AZT has a Gross Margin of 95.84%. This is amongst the best in the industry. AZT outperforms 91.36% of its industry peers.
  • In the last couple of years the Gross Margin of AZT has remained more or less at the same level.
Industry RankSector Rank
OM 2.5%
PM (TTM) 9.18%
GM 95.84%
OM growth 3Y-54.57%
OM growth 5Y-44.12%
PM growth 3Y-28.49%
PM growth 5Y-37.08%
GM growth 3Y-0.13%
GM growth 5Y-0.6%
AZT.OL Yearly Profit, Operating, Gross MarginsAZT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. AZT.OL Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AZT is destroying value.
  • Compared to 1 year ago, AZT has about the same amount of shares outstanding.
  • Compared to 5 years ago, AZT has more shares outstanding
  • The debt/assets ratio for AZT has been reduced compared to a year ago.
AZT.OL Yearly Shares OutstandingAZT.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
AZT.OL Yearly Total Debt VS Total AssetsAZT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 27.16 indicates that AZT is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 27.16, AZT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • AZT has a debt to FCF ratio of 0.24. This is a very positive value and a sign of high solvency as it would only need 0.24 years to pay back of all of its debts.
  • AZT has a Debt to FCF ratio of 0.24. This is amongst the best in the industry. AZT outperforms 93.83% of its industry peers.
  • AZT has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • AZT has a better Debt to Equity ratio (0.01) than 80.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.24
Altman-Z 27.16
ROIC/WACC0.08
WACC8.53%
AZT.OL Yearly LT Debt VS Equity VS FCFAZT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 16.39 indicates that AZT has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 16.39, AZT belongs to the top of the industry, outperforming 96.30% of the companies in the same industry.
  • AZT has a Quick Ratio of 15.53. This indicates that AZT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 15.53, AZT belongs to the top of the industry, outperforming 96.30% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 16.39
Quick Ratio 15.53
AZT.OL Yearly Current Assets VS Current LiabilitesAZT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. AZT.OL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 35.71% over the past year.
  • Measured over the past years, AZT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -34.95% on average per year.
  • The Revenue has been growing slightly by 7.92% in the past year.
  • AZT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.80% yearly.
EPS 1Y (TTM)35.71%
EPS 3Y-33.29%
EPS 5Y-34.95%
EPS Q2Q%116.67%
Revenue 1Y (TTM)7.92%
Revenue growth 3Y-6.32%
Revenue growth 5Y3.8%
Sales Q2Q%31.1%

3.2 Future

  • Based on estimates for the next years, AZT will show a very strong growth in Earnings Per Share. The EPS will grow by 74.81% on average per year.
  • Based on estimates for the next years, AZT will show a very strong growth in Revenue. The Revenue will grow by 35.40% on average per year.
EPS Next Y117.95%
EPS Next 2Y92.21%
EPS Next 3Y74.81%
EPS Next 5YN/A
Revenue Next Year26.73%
Revenue Next 2Y22.57%
Revenue Next 3Y20.85%
Revenue Next 5Y35.4%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AZT.OL Yearly Revenue VS EstimatesAZT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
AZT.OL Yearly EPS VS EstimatesAZT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

5

4. AZT.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • AZT is valuated quite expensively with a Price/Earnings ratio of 103.95.
  • 72.84% of the companies in the same industry are more expensive than AZT, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.89, AZT is valued quite expensively.
  • With a Price/Forward Earnings ratio of 47.69, AZT can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AZT indicates a somewhat cheap valuation: AZT is cheaper than 77.78% of the companies listed in the same industry.
  • AZT's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 38.50.
Industry RankSector Rank
PE 103.95
Fwd PE 47.69
AZT.OL Price Earnings VS Forward Price EarningsAZT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • AZT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AZT is cheaper than 71.60% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, AZT is valued cheaper than 82.72% of the companies in the same industry.
Industry RankSector Rank
P/FCF 45.5
EV/EBITDA 67.14
AZT.OL Per share dataAZT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • AZT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of AZT may justify a higher PE ratio.
  • A more expensive valuation may be justified as AZT's earnings are expected to grow with 74.81% in the coming years.
PEG (NY)0.88
PEG (5Y)N/A
EPS Next 2Y92.21%
EPS Next 3Y74.81%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AZT.OL Dividend Analysis

5.1 Amount

  • AZT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AZT.OL Fundamentals: All Metrics, Ratios and Statistics

ARCTICZYMES TECHNOLOGIES ASA

OSL:AZT (4/20/2026, 4:04:58 PM)

19.75

+0.45 (+2.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners14.7%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap1.01B
Revenue(TTM)112.62M
Net Income(TTM)10.34M
Analysts80
Price Target34.68 (75.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)102.97%
Min EPS beat(2)48.51%
Max EPS beat(2)157.43%
EPS beat(4)3
Avg EPS beat(4)33.31%
Min EPS beat(4)-269.73%
Max EPS beat(4)197.03%
EPS beat(8)4
Avg EPS beat(8)152.7%
EPS beat(12)6
Avg EPS beat(12)106.86%
EPS beat(16)7
Avg EPS beat(16)73.12%
Revenue beat(2)1
Avg Revenue beat(2)3.31%
Min Revenue beat(2)-5.88%
Max Revenue beat(2)12.5%
Revenue beat(4)2
Avg Revenue beat(4)-1.15%
Min Revenue beat(4)-13.1%
Max Revenue beat(4)12.5%
Revenue beat(8)3
Avg Revenue beat(8)-4.13%
Revenue beat(12)4
Avg Revenue beat(12)-5.44%
Revenue beat(16)5
Avg Revenue beat(16)-3.89%
PT rev (1m)0%
PT rev (3m)3.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.83%
Valuation
Industry RankSector Rank
PE 103.95
Fwd PE 47.69
P/S 8.96
P/FCF 45.5
P/OCF 39.08
P/B 2.98
P/tB 3.31
EV/EBITDA 67.14
EPS(TTM)0.19
EY0.96%
EPS(NY)0.41
Fwd EY2.1%
FCF(TTM)0.43
FCFY2.2%
OCF(TTM)0.51
OCFY2.56%
SpS2.21
BVpS6.63
TBVpS5.96
PEG (NY)0.88
PEG (5Y)N/A
Graham Number5.32284 (-73.05%)
Profitability
Industry RankSector Rank
ROA 2.86%
ROE 3.05%
ROCE 0.82%
ROIC 0.66%
ROICexc 1.46%
ROICexgc 1.88%
OM 2.5%
PM (TTM) 9.18%
GM 95.84%
FCFM 19.69%
ROA(3y)3.64%
ROA(5y)7.51%
ROE(3y)3.94%
ROE(5y)8.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-70.15%
ROICexgc growth 5Y-48.7%
ROICexc growth 3Y-70.63%
ROICexc growth 5Y-51.12%
OM growth 3Y-54.57%
OM growth 5Y-44.12%
PM growth 3Y-28.49%
PM growth 5Y-37.08%
GM growth 3Y-0.13%
GM growth 5Y-0.6%
F-Score7
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.24
Debt/EBITDA 0.35
Cap/Depr 39.79%
Cap/Sales 3.23%
Interest Coverage 10.57
Cash Conversion 215.75%
Profit Quality 214.43%
Current Ratio 16.39
Quick Ratio 15.53
Altman-Z 27.16
F-Score7
WACC8.53%
ROIC/WACC0.08
Cap/Depr(3y)161.89%
Cap/Depr(5y)219.35%
Cap/Sales(3y)9.51%
Cap/Sales(5y)9.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.71%
EPS 3Y-33.29%
EPS 5Y-34.95%
EPS Q2Q%116.67%
EPS Next Y117.95%
EPS Next 2Y92.21%
EPS Next 3Y74.81%
EPS Next 5YN/A
Revenue 1Y (TTM)7.92%
Revenue growth 3Y-6.32%
Revenue growth 5Y3.8%
Sales Q2Q%31.1%
Revenue Next Year26.73%
Revenue Next 2Y22.57%
Revenue Next 3Y20.85%
Revenue Next 5Y35.4%
EBIT growth 1Y295.28%
EBIT growth 3Y-57.44%
EBIT growth 5Y-41.99%
EBIT Next Year1933.33%
EBIT Next 3Y259.17%
EBIT Next 5YN/A
FCF growth 1Y381.95%
FCF growth 3Y-21.56%
FCF growth 5Y-13.13%
OCF growth 1Y1455.88%
OCF growth 3Y-23.81%
OCF growth 5Y-11.2%

ARCTICZYMES TECHNOLOGIES ASA / AZT.OL Fundamental Analysis FAQ

What is the fundamental rating for AZT stock?

ChartMill assigns a fundamental rating of 6 / 10 to AZT.OL.


What is the valuation status for AZT stock?

ChartMill assigns a valuation rating of 5 / 10 to ARCTICZYMES TECHNOLOGIES ASA (AZT.OL). This can be considered as Fairly Valued.


How profitable is ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) stock?

ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) has a profitability rating of 6 / 10.


What is the valuation of ARCTICZYMES TECHNOLOGIES ASA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) is 103.95 and the Price/Book (PB) ratio is 2.98.


How financially healthy is ARCTICZYMES TECHNOLOGIES ASA?

The financial health rating of ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) is 8 / 10.